A simple and sensitive liquid chromatographic technique for the determination of cefotetan disodium in human plasma and its application in a pharmacokinetic study

Abstract

A simple and sensitive liquid chromatographic method was developed for quantification of cefotetan disodium (CTT), a semi-synthetic cephamycin antibiotic, in human plasma. CTT and the internal standard chloramphenicol were extracted from plasma by a simple one-step protein precipitation with 35% (v/v) perchloric acid. Separation was carried out on a reverse-phase C18 column with a mobile phase of acetonitile-water containing 0.5% (v/v) phosphoric acids (20:80, v/v) at a flow rate of 1.0 mL/min. The column effluent was monitored by UV detection at 300 nm. The column temperature was maintained at 40°C. This method demonstrated good linearity in the range of 0.525–300.0 μg/mL, with correlation coefficients greater than 0.99. The limit of quantification (LOQ) was 0.525 μg/mL in human plasma. Intra- and inter-day precisions were less than 6.63% in terms of relative standard deviation (RSD). The accuracy, when expressed by the bias, ranged from 0.57% to 4.04%. The mean extraction recovery of CTT was higher than 40.94%. The method was found to be precise, accurate, and specific for CTT quantitative analysis, and was successfully applied for a pharmacokinetic study of CTT after a single intravenous dose of 1.0 g of CTT in healthy Chinese subjects.

Keywords

cefotetan disodium / liquid chromatography / human plasma / pharmacokinetics

References

[1] ShiS.J., LiuY.N., LiZ.F., et al.. Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study. Clin Ther, 2010, 32(10): 1832-1841

[2] http://www.rxlist.com/cefotan-drug.htm. Accessed Jan 29 2012

[3] WardA., RichardsD.M.. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs, 1985, 30(5): 382-426

[4] MartinC., PortetC., LambertD., et al.. Pharmacokinetics and tissue penetration of single-dose cefotetan used for antimicrobial prophylaxis in patients undergoing colorectal surgery. Antimicrob Agents Chemother, 1992, 36(5): 1115-1118

[5] MoineP., AsehnouneK.. Antibiotic prophylaxis in colorectal surgery. N Engl J Med, 2007, 356(16): 1684-1685

[6] BratzlerD.W., HouckP.M.. Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg, 2005, 189(4): 395-404

[7] ChristineF., DonF., DonaldF.B., et al.. High-performance liquid chromatographic determination of cefepime and cefazolin in human plasma and dialysate. Chromatographia, 2008, 67(5–6): 365-368

[8] SmithB.R., LeFrockJ.L., ThyrumP.T., et al.. Cefotetan pharmacokinetics in volunteers with various degrees of renal function. Antimicrob Agents Chemother, 1986, 29(5): 887-893

[9] OhkawaM., HiranoS., TokunagaS., et al.. Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function. Antimicrob Agents Chemother, 1983, 23(1): 31-35

[10] Das GuptaV., PramarY., OdomC., et al.. Chemical stability of cefotetan disodium in 5% dextrose and 0.9% sodium chloride injections. J Clin Pharm Ther, 1990, 15(2): 109-114

[11] SongG.J., LouQ.X.. Study on polymer of cefotetan disodium by gel chromatography. J Modern Food Pharm (Chinese), 2007, 17(5): 52-54

[12] MariniD., BalestrieriF., PollinoG., et al.. HPLC determination of cefotetan and its principle impurities. Boll Chim Farm, 1987, 126(2): 60-65

[13] GuibertJ., KitzisM.D., YvelinC., et al.. Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers. J Antimicrob Chemother, 1983, 11(supplA): 201-206

[14] NakagawaK., KoyamaM., TachibanaA., et al.. Pharmacokinetics of cefotetan (YM09330) in humans. Antimicrob Agents Chemother, 1982, 22(6): 935-941

[15] KeesF., GrobeckerH., NaberK.G.. High-performance liquid chromatographic analysis of cefotetan epimers in human plasma and urine. J Chromatogr, 1984, 305(2): 363-371

[16] AdamH.K., HoughtonH.L., YatesR.A., et al.. Pharmacokinetics and tolerance of a 24-h infusion of cefotetan disodium (with and without loading dose) in normal Caucasian volunteers. J Antimicrob Chemother, 1983, 11(supplA): 193-199

[17] Guidance for Industry Bioanalytical Method Validation (2001) US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine

[18] YatesR.A., AdamH.K., DonnellyR.J., et al.. Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers. J Antimicrob Chemother, 1983, 11(supplA): 185-191

[19] MartinC., ThomachotL., AlbaneseJ.. Clinical pharmacokinetics of cefotetan. Clin Pharmacokinet, 1994, 26(4): 248-258